Back to search

Article

Associations of Systemic Inflammation and Senescent Cell Biomarkers with Clinical Outcomes in Older Adults with Schizophrenia

2024-03-08

Abstract excerpt

Individuals with schizophrenia suffer from higher morbidity and mortality throughout life partly due to acceleration of aging-related diseases and conditions. Systemic inflammation is a hallmark of aging and is also observed in schizophrenia. An improved understanding of how inflammation and accelerated aging contribute to long-term health outcomes in schizophrenia could provide more effective treatments to preser...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5e281270-4829-5607-b4bb-8d0768d5853c
DOI
10.1101/2024.03.06.24303857
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Associations of Systemic Inflammation and Senescent Cell Biomarkers with Clinical Outcomes in Older Adults with SchizophreniaDOI 10.1101/2024.03.06.24303857
Systemic Biomarkers of Accelerated Aging in Schizophrenia: A Critical Review and Future DirectionsSemantic proximity
In Schizophrenia, Depression and Anxiety Symptoms Are Driven by Immune-Inflammatory Pathways.Semantic proximity
The role of the epidermal growth factor in the pathogenesis of schizophrenia. Clinical and diagnostic value.Semantic proximity
Neuro-Immune Aspects of Schizophrenia with Severe Negative Symptoms: New Diagnostic Markers of Disease Phenotype.Semantic proximity
Monocytic Subsets and Their Signature Genes Differentially Impact Cortex and Cognition in First-Episode SchizophreniaSemantic proximity
Meta-analyses of epigenetic age acceleration and GrimAge components of schizophrenia or first-episode psychosisSemantic proximity
Complete blood count-derived inflammatory markers and symptom phenotypes in schizophrenia spectrum disorders: A hierarchical clustering analysis.Semantic proximity
The potential of immune biomarkers to advance personalized medicine approaches for schizophrenia.Semantic proximity
Temporal changes in brain morphology related to inflammation and schizophrenia: an omnigenic Mendelian randomization study.Semantic proximity
Consensus on potential biomarkers developed for use in clinical tests for schizophreniaSemantic proximity
A new schizophrenia model: immune activation is associated with induction of the tryptophan catabolite pathway and increased eotaxin levels which together determine memory impairments and schizophrenia symptom dimensionsSemantic proximity
Plasma Levels of Neuron- and Astrocyte-Derived Exosomal Amyloid Beta1-42, Amyloid Beta1-40, and Phosphorylated Tau Levels in Schizophrenia Patients and Non-psychiatric Comparison Subjects: Relationships With Cognitive Functioning and PsychopathologySemantic proximity
Select a neighboring publication to make it the new centre.